Yahoo
NasdaqGS - Delayed Quote USD

Boundless Bio, Inc. (BOLD)

2.4700 -0.0100 (-0.40%)
At close: October 30 at 4:00:00 PM EDT
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
0
0
0
0
0
Operating Expense
68,009
63,552
73,267
54,796
46,469
Operating Income
-68,009
-63,552
-73,267
-54,796
-46,469
Net Non Operating Interest Income Expense
3,996
5,357
7,892
5,282
668
Other Income Expense
1
-2
12
80
-100
Pretax Income
-64,012
-58,197
-65,363
-49,434
-45,901
Net Income Common Stockholders
-64,012
-58,197
-65,363
-49,434
-45,901
Diluted NI Available to Com Stockholders
-64,012
-58,197
-65,363
-49,434
-45,901
Basic EPS
-2.85
-2.60
-3.85
-2.22
-3.28
Diluted EPS
-2.85
-2.60
-3.85
-2.22
-3.28
Basic Average Shares
22,410.5000
22,360
16,984
22,239.3330
13,990
Diluted Average Shares
22,410.5000
22,360
16,984
22,239.3330
13,990
Total Operating Income as Reported
-68,009
-63,552
-73,267
-54,796
-46,469
Total Expenses
68,009
63,552
73,267
54,796
46,469
Net Income from Continuing & Discontinued Operation
-64,012
-58,197
-65,363
-49,434
-45,901
Normalized Income
-64,012
-58,197
-65,363
-49,434
-45,901
Interest Income
3,996
5,357
7,892
5,282
668
Net Interest Income
3,996
5,357
7,892
5,282
668
EBIT
-68,009
-63,552
-73,267
-54,796
-46,469
EBITDA
-65,851
-62,301
-72,181
-53,839
-45,527
Reconciled Depreciation
2,158
1,251
1,086
957
942
Net Income from Continuing Operation Net Minority Interest
-64,012
-58,197
-65,363
-49,434
-45,901
Normalized EBITDA
-65,851
-62,301
-72,181
-53,839
-45,527
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2022 - 3/28/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: